3 ms·
I think they could be, because I think you're looking for that 1/1000. Doing 1000 things and throwing away 999 is expensive. So sure, when you look at that 1/10
by consteval 2y ago
I think they could be, because I think you're looking for that 1/1000. Doing 1000 things and throwing away 999 is expensive. So sure, when you look at that 1/1000 you might say "oh the 1 isn't expensive". But you're also paying for the 999, and you have to in order to get that 1.
- someNameIG 2y agoTrue that a big part of the cost is absorbing the costs of failed drugs, but most of it is in clinical trials, which is normally past the academia setting.
- consteval 2y agoIf I had to guess, a tiny tiny percent of all potential drugs make it to clinical trails. So again, now you're looking at 1 in 10,000. You're only looking at the 1, ignoring the 9,999, and saying "look pharma pays for all of it!" How much research at unis ends up being completely worthless from a pharmaceutical product perspective? Almost all of it. But how many products began based on research conducted at universities? ... all of them.